US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SILO PHARMA INC.

0.5811

-0.0589-9.20%

Post-market: 0.5600-0.0211-3.63%19:59 EDT

Volume:6.36M

Turnover:4.38M

Market Cap:4.19M

PE:-0.51

High:0.7900

Open:0.6326

Low:0.5800

Close:0.6400

Loading ...

Overview Company News Filings

Silo Pharma Inc. Board Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset for Long-Term Value Optimization

Eric Weisblum, CEO of Silo Pharma Inc., Reports Acquisition of Common Shares

Silo Pharma Collaborates With Resyca for Drug-Device Study of PTSD Drug SPC-15

MT Newswires Live

Silo Pharma, Resyca partner for intranasal drug-device study of SPC-15

Silo Pharma Partners With Resyca for Ind-Supporting Intranasal Drug-Device Study of Ptsd Drug Spc-15

THOMSON REUTERS

Silo Pharma Initiates Intranasal Drug-Device Study for PTSD Treatment, Partners with Resyca for IND Submission

BRIEF-Silo Pharma Announces Closing Of $2 Million Public Offering

Silo Pharma Inc. Completes $2 Million Public Offering of Common Stock and Warrants

Silo Pharma Announces Closing of $2 Million Public Offering

THOMSON REUTERS

Silo Pharma Announces $2 Million Public Offering of Shares and Warrants

Silo Pharma Announces Pricing of $2 Million Public Offering

THOMSON REUTERS

Silo Pharma Engages Veloxity Labs for IND-Enabling Study of Intranasal PTSD Therapy SPC-15

Silo Pharma Inc. Initiates Key Safety Study for PTSD Drug SPC-15, Paving Way for First-in-Human Trials

Silo Pharma Inc: Currently Remain on Track to Begin an FDA Submission This Year.

THOMSON REUTERS

Silo Pharma Inc - Study to Supplement Spc-15 Ind Application to FDA

THOMSON REUTERS

Silo Pharma Advances Ptsd Drug Spc-15 Toward First-in-Human Trial With Key Safety Study Initiated at Frontage Laboratories

THOMSON REUTERS

BRIEF-Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints In Fibromyalgia Study

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

THOMSON REUTERS

Silo Pharma Inc - No Implant-Related Adverse Events Observed in Study

THOMSON REUTERS

BRIEF-Silo Pharma Expands Intellectual Property Portfolio With Patent Application For Exclusively Licensed Alzheimer’S Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SILO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SILO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SILO\",,,,,undefined,":{"symbol":"SILO","market":"US","secType":"STK","nameCN":"SILO PHARMA INC.","latestPrice":0.5811,"timestamp":1749240000000,"preClose":0.64,"halted":0,"volume":6361051,"hourTrading":{"tag":"盘后","latestPrice":0.56,"preClose":0.5811,"latestTime":"19:59 EDT","volume":229312,"amount":129791.8287,"timestamp":1749254391126},"delay":0,"floatShares":7014900,"shares":7207792,"eps":-1.131679,"marketStatus":"Market Closed","change":-0.0589,"latestTime":"06-06 16:00:00 EDT","open":0.6326,"high":0.79,"low":0.58,"amount":4375903.4910544595,"amplitude":0.328125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.131679,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.64,"preHourTrading":{"tag":"盘前","latestPrice":0.6369,"preClose":0.64,"latestTime":"09:29 EDT","volume":96916,"amount":58224.748666399995,"timestamp":1749216546232},"postHourTrading":{"tag":"盘后","latestPrice":0.56,"preClose":0.5811,"latestTime":"19:59 EDT","volume":229312,"amount":129791.8287,"timestamp":1749254391126},"volumeRatio":1.057257442274245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SILO\",,,,,undefined,":{"symbol":"SILO","floatShares":7014900,"roa":"-47.89%","roe":"-99.38%","lyrEps":-1.193591,"volumeRatio":1.057257442274245,"shares":7207792,"dividePrice":0,"high":0.79,"amplitude":0.328125,"preClose":0.64,"low":0.58,"week52Low":0.4101,"pbRate":"1.04","psRate":"58.09","week52High":4.5,"institutionHeld":0,"latestPrice":0.5811,"eps":-1.131679,"divideRate":0,"volume":6361051,"delay":0,"ttmEps":-1.131679,"open":0.6326,"prevYearClose":0.89,"prevWeekClose":0.4444,"prevMonthClose":0.4444,"prevQuarterClose":1.17,"fiveDayClose":0.4444,"twentyDayClose":0.8149,"sixtyDayClose":1.3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SILO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541734650","title":"Silo Pharma Inc. Board Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset for Long-Term Value Optimization","url":"https://stock-news.laohu8.com/highlight/detail?id=2541734650","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541734650?lang=en_us&edition=fundamental","pubTime":"2025-06-05 21:15","pubTimestamp":1749129309,"startTime":"0","endTime":"0","summary":"Silo Pharma, Inc. , a developmental stage biopharmaceutical company, announced that its Board of Directors has approved the purchase of up to $1 million in Bitcoin as a treasury reserve asset. This strategic decision aims to diversify the company's assets by incorporating a digital store of value, potentially offering significant upside. CEO Eric Weisblum explained that the move is intended to safeguard against inflation and enhance long-term shareholder value.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief via GlobeNewswire  on June 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL2h1pw7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4112","LU2210149790.SGD","BK4139","BK4202","IE00BKPKM429.USD","LU2210150020.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NDAQ","BK4585","SILO","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2539240921","title":"Eric Weisblum, CEO of Silo Pharma Inc., Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2539240921","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539240921?lang=en_us&edition=fundamental","pubTime":"2025-05-29 04:31","pubTimestamp":1748464283,"startTime":"0","endTime":"0","summary":"Eric Weisblum, Chief Executive Officer and Director of Silo Pharma Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL8lhhN7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Eric Weisblum, CEO of Silo Pharma Inc., Reports Acquisition of Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4202","SILO"],"gpt_icon":0},{"id":"2537351299","title":"Silo Pharma Collaborates With Resyca for Drug-Device Study of PTSD Drug SPC-15","url":"https://stock-news.laohu8.com/highlight/detail?id=2537351299","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537351299?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:20","pubTimestamp":1747833605,"startTime":"0","endTime":"0","summary":"Silo Pharma  said Wednesday that it has signed a service agreement with medical technology firm Resyca for a drug-device study of its lead asset SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder, or PTSD.Financial details were not disclosed.Silo said the study is expected to provide the necessary device data and documentation for SPC-15's investigational new drug application, which the company plans to submit to the US Food and Drug Administration this year.Silo is currently conducting two additional SPC-15 studies, it said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPC","BK4139","SILO","BK4202"],"gpt_icon":0},{"id":"2537935383","title":"Silo Pharma, Resyca partner for intranasal drug-device study of SPC-15","url":"https://stock-news.laohu8.com/highlight/detail?id=2537935383","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537935383?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:00","pubTimestamp":1747832425,"startTime":"0","endTime":"0","summary":"Silo Pharma (SILO) has entered into a service agreement with medical technology provider Resyca BV for a drug-device study of the formulation-speci...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/silo-pharma-resyca-partner-for-intranasal-drug-device-study-of-spc-15?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/silo-pharma-resyca-partner-for-intranasal-drug-device-study-of-spc-15?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SILO","BK4139","SPC","BK4202"],"gpt_icon":0},{"id":"2537933156","title":"Silo Pharma Partners With Resyca for Ind-Supporting Intranasal Drug-Device Study of Ptsd Drug Spc-15","url":"https://stock-news.laohu8.com/highlight/detail?id=2537933156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537933156?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:55","pubTimestamp":1747832113,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nFWN3RT0QT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SILO","BK4202","BK4139"],"gpt_icon":0},{"id":"2537933163","title":"Silo Pharma Initiates Intranasal Drug-Device Study for PTSD Treatment, Partners with Resyca for IND Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2537933163","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537933163?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:55","pubTimestamp":1747832112,"startTime":"0","endTime":"0","summary":"Silo Pharma Inc. has announced a new clinical study in collaboration with Resyca BV, focusing on the drug-device combination for their lead asset, SPC-15. The study aims to collect the final device data and documentation necessary for an Investigational New Drug  submission to the U.S. Food and Drug Administration  later this year. SPC-15 is designed as an intranasal treatment for post-traumatic stress disorder  and utilizes a microchip-based nasal spray system to deliver molecules directly to the brain, bypassing the blood-brain barrier. This approach is intended to increase drug concentration and potentially enhance therapeutic outcomes. Currently, Silo Pharma is also conducting an IND-enabling GLP-compliant toxicology and toxicokinetics study, along with an FDA-requested 7-day safety and toxicology study in large animals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL7464vq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4202","IE00BKPKM429.USD","BK4139","IE00B64PRP62.GBP","SILO","LU2210149790.SGD","LU2095319765.USD","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","BK4112","IE00B3QW5Z07.USD","BK4585"],"gpt_icon":0},{"id":"2536340263","title":"BRIEF-Silo Pharma Announces Closing Of $2 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2536340263","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536340263?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:15","pubTimestamp":1747426525,"startTime":"0","endTime":"0","summary":"BRIEF-Silo Pharma Announces Closing Of $2 Million Public OfferingMay 16 (Reuters) - Silo Pharma Inc SILO.O:SILO PHARMA ANNOUNCES CLOSING OF $2 MILLION PUBLIC OFFERINGSource text: ID:nGNX7k4ScbFurther company coverage: SILO.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nTUADPPTB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SILO","BK4202"],"gpt_icon":0},{"id":"2536234025","title":"Silo Pharma Inc. Completes $2 Million Public Offering of Common Stock and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2536234025","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536234025?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:15","pubTimestamp":1747426520,"startTime":"0","endTime":"0","summary":"Silo Pharma Inc., a developmental stage biopharmaceutical company, has successfully closed a public offering, raising approximately $2 million. The offering involved 3,333,338 shares of common stock, along with series A-1 and series A-2 warrants, each allowing the purchase of up to 3,333,338 additional shares at an exercise price of $0.60 per share. The Series A-1 Warrants are exercisable immediately and expire in five years, while the Series A-2 Warrants also become exercisable immediately but expire in eighteen months. The funds raised will be used for general working capital. H.C. Wainwright & Co. served as the exclusive placement agent for this offering.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDLb5K3qw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NDAQ","BK4112","BK4202","LU2210149790.SGD","BK4588","LU2095319765.USD","BK4585","IE00B64PRP62.GBP","IE00BKPKM429.USD","SILO","BK4139","LU2210150020.SGD"],"gpt_icon":0},{"id":"2536734023","title":"Silo Pharma Announces Closing of $2 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2536734023","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536734023?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:15","pubTimestamp":1747426500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nTUADPPTB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4202","BK4139","SILO"],"gpt_icon":0},{"id":"2535470823","title":"Silo Pharma Announces $2 Million Public Offering of Shares and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2535470823","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535470823?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:15","pubTimestamp":1747314912,"startTime":"0","endTime":"0","summary":"Silo Pharma Inc., a developmental stage biopharmaceutical company, has announced the pricing of a $2 million public offering. The offering includes 3,333,338 shares of common stock along with Series A-1 and Series A-2 warrants, each allowing the purchase of an additional 3,333,338 shares at $0.60 per share. The Series A-1 Warrants will expire five years from issuance, and the Series A-2 Warrants will expire eighteen months from issuance. H.C. Wainwright & Co. is serving as the exclusive placement agent for this offering. The company plans to use the proceeds for general working capital purposes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief via GlobeNewsw","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL4YwHlW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4585","LU2210149790.SGD","LU2210150020.SGD","BK4112","BK4202","BK4139","SILO","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4588","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2535982347","title":"Silo Pharma Announces Pricing of $2 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2535982347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535982347?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:15","pubTimestamp":1747314900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA6ZTJGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4202","SILO"],"gpt_icon":0},{"id":"2535007979","title":"Silo Pharma Engages Veloxity Labs for IND-Enabling Study of Intranasal PTSD Therapy SPC-15","url":"https://stock-news.laohu8.com/highlight/detail?id=2535007979","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535007979?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:15","pubTimestamp":1747253712,"startTime":"0","endTime":"0","summary":"Silo Pharma Inc. has announced a significant step in the development of its novel intranasal PTSD therapy, SPC-15. The biopharmaceutical company, focused on pioneering therapeutics and drug delivery systems, has partnered with Veloxity Labs, LLC for a bioanalytical study necessary for the investigational new drug -enabling process. This collaboration aims to support the ongoing GLP-compliant toxicology and toxicokinetics study of SPC-15. Silo Pharma plans to initiate the FDA IND process later in 2025, with hopes of progressing to a first-in-human Phase 1 clinical trial following approval. The CEO, Eric Weisblum, highlighted the importance of Veloxity Labs in providing fast and precise data crucial for advancing SPC-15 into clinical trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be int","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL5jKkl6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4588","NDAQ","SILO","IE00BKPKM429.USD","LU2210149790.SGD","BK4112","LU2095319765.USD","BK4202","BK4139","LU2210150020.SGD","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2535213170","title":"Silo Pharma Inc. Initiates Key Safety Study for PTSD Drug SPC-15, Paving Way for First-in-Human Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2535213170","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535213170?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:40","pubTimestamp":1747226412,"startTime":"0","endTime":"0","summary":"Silo Pharma Inc. , a developmental stage biopharmaceutical company, has announced a significant step forward in the development of its PTSD drug, SPC-15. The company has initiated a 7-day safety and toxicology study at Frontage Laboratories, a global contract research organization. This study, requested by the FDA, aims to gather crucial data to support Silo's investigational new drug  application for SPC-15, an intranasal prophylactic treatment targeting the multi-billion-dollar PTSD market. The company remains on track to submit an FDA application this year, with plans to proceed to a first-in-human Phase 1 clinical trial upon approval. Silo has an exclusive global license from Columbia University for the development and commercialization of SPC-15.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shoul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL8FlPgQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK0216","300347","LU2095319765.USD","BK0077","BK4588","IE00BKPKM429.USD","LU1820825898.SGD","BK4585","LU1146622755.USD","NDAQ","BK4139","BK0174","LU2210150020.SGD","LU2210149790.SGD","IE00B64PRP62.GBP","SILO","BK0028","BK4112"],"gpt_icon":0},{"id":"2535402139","title":"Silo Pharma Inc: Currently Remain on Track to Begin an FDA Submission This Year.","url":"https://stock-news.laohu8.com/highlight/detail?id=2535402139","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535402139?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:40","pubTimestamp":1747226409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1SR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4202","SILO","BK4139"],"gpt_icon":0},{"id":"2535021399","title":"Silo Pharma Inc - Study to Supplement Spc-15 Ind Application to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2535021399","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535021399?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:40","pubTimestamp":1747226409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1SR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SILO","BK4202","BK4139"],"gpt_icon":0},{"id":"2535021339","title":"Silo Pharma Advances Ptsd Drug Spc-15 Toward First-in-Human Trial With Key Safety Study Initiated at Frontage Laboratories","url":"https://stock-news.laohu8.com/highlight/detail?id=2535021339","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535021339?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:40","pubTimestamp":1747226409,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1SR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4202","BK4139","SILO"],"gpt_icon":0},{"id":"2531031360","title":"BRIEF-Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints In Fibromyalgia Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2531031360","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531031360?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:13","pubTimestamp":1746015191,"startTime":"0","endTime":"0","summary":"BRIEF-Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints In Fibromyalgia StudyApril 30 (Reuters) - Silo Pharma Inc SILO.O:SILO PHARMA’S SP-26 KETAMINE IMPLANT MEETS ALL ENDPOINTS IN FIBROMYALGIA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA6W9G1K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4202","SILO"],"gpt_icon":0},{"id":"2531603133","title":"Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2531603133","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531603133?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:11","pubTimestamp":1746015060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA6W9G1K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SILO","BK4202"],"gpt_icon":0},{"id":"2531031358","title":"Silo Pharma Inc - No Implant-Related Adverse Events Observed in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2531031358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531031358?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:11","pubTimestamp":1746015060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA6W9G1K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SILO","BK4139","BK4202"],"gpt_icon":0},{"id":"2530894662","title":"BRIEF-Silo Pharma Expands Intellectual Property Portfolio With Patent Application For Exclusively Licensed Alzheimer’S Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2530894662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530894662?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:57","pubTimestamp":1745848677,"startTime":"0","endTime":"0","summary":"BRIEF-Silo Pharma Expands Intellectual Property Portfolio With Patent Application For Exclusively Licensed Alzheimer’S DrugApril 28 (Reuters) - Silo Pharma Inc SILO.O:SILO PHARMA EXPANDS INTELLECTUAL ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R60U7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4202","SILO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SILO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-09","symbol":"SILO","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2025-03-28","symbol":"SILO","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"post","actualEps":-0.41},{"market":"US","date":"2024-11-12","symbol":"SILO","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2024-08-13","symbol":"SILO","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2024-05-13","symbol":"SILO","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.28}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SILO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SILO\",market:\"US\",delay:true,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SILO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"SILO","date":"2025-06-05","current":-0.890322,"percent":0.772358,"low":-49.251422,"twenty":-7.471816,"median":-1.537812,"eighty":2.513243,"high":6.268511,"avg":-4.109719,"sd":8.821249,"marketCap":4115649},"quantilePoints":[{"date":"2020-06-12","current":-36.938566,"twenty":-47.831013,"median":-11.316925,"eighty":-7.933662,"marketCap":37429627},{"date":"2020-06-19","current":-36.938566,"twenty":-47.831013,"median":-11.316925,"eighty":-8.383446,"marketCap":37429627},{"date":"2020-06-26","current":-36.938566,"twenty":-47.831013,"median":-11.316925,"eighty":-8.383446,"marketCap":37429627},{"date":"2020-07-02","current":-36.938566,"twenty":-47.831013,"median":-11.316925,"eighty":-8.383446,"marketCap":37429627},{"date":"2020-07-10","current":-36.938566,"twenty":-47.831013,"median":-11.316925,"eighty":-8.383446,"marketCap":37429627},{"date":"2020-07-17","current":-36.938566,"twenty":-47.831013,"median":-11.543264,"eighty":-8.383446,"marketCap":37429627},{"date":"2020-07-24","current":-36.938566,"twenty":-47.831013,"median":-11.610032,"eighty":-8.383446,"marketCap":37429627},{"date":"2020-07-31","current":-40.550337,"twenty":-47.831013,"median":-11.610032,"eighty":-8.383446,"marketCap":41089413},{"date":"2020-08-07","current":-40.550337,"twenty":-47.831013,"median":-11.610032,"eighty":-8.383446,"marketCap":41089413},{"date":"2020-08-14","current":-22.589384,"twenty":-47.831013,"median":-11.610032,"eighty":-8.383446,"marketCap":51085170},{"date":"2020-08-21","current":-22.589384,"twenty":-47.831013,"median":-11.610032,"eighty":-8.383446,"marketCap":51085170},{"date":"2020-08-28","current":-22.589384,"twenty":-47.831013,"median":-11.610032,"eighty":-8.383446,"marketCap":51085170},{"date":"2020-09-04","current":-15.812569,"twenty":-47.831013,"median":-11.920554,"eighty":-8.383446,"marketCap":35759619},{"date":"2020-09-11","current":-15.812569,"twenty":-46.11557,"median":-11.920554,"eighty":-8.383446,"marketCap":35759619},{"date":"2020-09-18","current":-13.177141,"twenty":-44.971941,"median":-11.920554,"eighty":-8.383446,"marketCap":29799682},{"date":"2020-09-25","current":-13.177141,"twenty":-44.971941,"median":-11.920554,"eighty":-8.383446,"marketCap":29799682},{"date":"2020-10-02","current":-13.177141,"twenty":-44.971941,"median":-12.605588,"eighty":-8.383446,"marketCap":29799682},{"date":"2020-10-09","current":-15.05959,"twenty":-44.971941,"median":-13.177141,"eighty":-8.383446,"marketCap":34056780},{"date":"2020-10-16","current":-17.318528,"twenty":-44.598482,"median":-13.177141,"eighty":-8.383446,"marketCap":39165297},{"date":"2020-10-23","current":-15.812569,"twenty":-44.34951,"median":-13.177141,"eighty":-8.383446,"marketCap":35759619},{"date":"2020-10-30","current":-7.529795,"twenty":-44.34951,"median":-13.177141,"eighty":-8.383446,"marketCap":17028390},{"date":"2020-11-06","current":-13.59794,"twenty":-42.414259,"median":-13.177141,"eighty":-8.383446,"marketCap":35759619},{"date":"2020-11-13","current":-13.921701,"twenty":-41.124091,"median":-13.177141,"eighty":-8.383446,"marketCap":36611038},{"date":"2020-11-20","current":-11.250677,"twenty":-41.124091,"median":-12.988896,"eighty":-8.383446,"marketCap":29586827},{"date":"2020-11-27","current":-11.979138,"twenty":-41.124091,"median":-12.950419,"eighty":-8.383446,"marketCap":31502521},{"date":"2020-12-04","current":-13.921701,"twenty":-41.124091,"median":-12.969658,"eighty":-8.383446,"marketCap":36611038},{"date":"2020-12-11","current":-14.083581,"twenty":-41.124091,"median":-12.950419,"eighty":-8.383446,"marketCap":37036748},{"date":"2020-12-18","current":-15.540503,"twenty":-40.894589,"median":-13.177141,"eighty":-8.383446,"marketCap":40868136},{"date":"2020-12-24","current":-13.59794,"twenty":-40.550337,"median":-13.177141,"eighty":-8.395489,"marketCap":35759619},{"date":"2020-12-31","current":-13.740395,"twenty":-40.550337,"median":-13.177141,"eighty":-8.44366,"marketCap":36134243},{"date":"2021-01-08","current":-11.331617,"twenty":-40.550337,"median":-13.177141,"eighty":-8.44366,"marketCap":29799682},{"date":"2021-01-15","current":-11.331617,"twenty":-40.550337,"median":-13.177141,"eighty":-8.44366,"marketCap":29799682},{"date":"2021-01-22","current":-11.338092,"twenty":-40.550337,"median":-12.969658,"eighty":-8.44366,"marketCap":29816710},{"date":"2021-01-29","current":-11.299241,"twenty":-40.550337,"median":-12.626659,"eighty":-8.44366,"marketCap":29714540},{"date":"2021-02-05","current":-11.623001,"twenty":-40.550337,"median":-12.545718,"eighty":-8.44366,"marketCap":30565960},{"date":"2021-02-12","current":-13.279636,"twenty":-40.550337,"median":-12.464778,"eighty":-8.44366,"marketCap":34922549},{"date":"2021-02-19","current":-12.955743,"twenty":-40.550337,"median":-12.464778,"eighty":-8.44366,"marketCap":34070780},{"date":"2021-02-26","current":-10.040701,"twenty":-40.410776,"median":-12.305427,"eighty":-8.44366,"marketCap":26404854},{"date":"2021-03-05","current":-9.230967,"twenty":-40.317736,"median":-12.222279,"eighty":-8.44366,"marketCap":24275430},{"date":"2021-03-12","current":-9.959727,"twenty":-40.317736,"median":-12.120246,"eighty":-8.44366,"marketCap":26191912},{"date":"2021-03-19","current":-10.364594,"twenty":-40.317736,"median":-11.979138,"eighty":-8.44366,"marketCap":27256624},{"date":"2021-03-26","current":-9.52571,"twenty":-40.317736,"median":-11.920554,"eighty":-8.44366,"marketCap":25050540},{"date":"2021-04-01","current":-8.412491,"twenty":-40.317736,"median":-11.920554,"eighty":-8.44366,"marketCap":25553085},{"date":"2021-04-09","current":-8.412491,"twenty":-38.966068,"median":-11.920554,"eighty":-8.44366,"marketCap":25553085},{"date":"2021-04-16","current":-9.193088,"twenty":-36.938566,"median":-11.920554,"eighty":-8.44366,"marketCap":27924161},{"date":"2021-04-23","current":-9.745323,"twenty":-36.938566,"median":-11.660169,"eighty":-8.44366,"marketCap":29601585},{"date":"2021-04-30","current":-8.780536,"twenty":-36.938566,"median":-11.655378,"eighty":-8.44366,"marketCap":26671028},{"date":"2021-05-07","current":-8.283525,"twenty":-36.938566,"median":-11.65214,"eighty":-8.44366,"marketCap":25161347},{"date":"2021-05-14","current":-9.745323,"twenty":-36.938566,"median":-11.610032,"eighty":-8.412491,"marketCap":29601585},{"date":"2021-05-21","current":-6.887088,"twenty":-36.938566,"median":-11.610032,"eighty":-8.383446,"marketCap":25684308},{"date":"2021-05-28","current":-6.482277,"twenty":-36.938566,"median":-11.610032,"eighty":-8.383446,"marketCap":24174627},{"date":"2021-06-04","current":-6.614568,"twenty":-36.938566,"median":-11.610032,"eighty":-8.383446,"marketCap":24667987},{"date":"2021-06-11","current":-7.530024,"twenty":-36.938566,"median":-11.610032,"eighty":-8.383446,"marketCap":28082036},{"date":"2021-06-18","current":-6.74686,"twenty":-36.938566,"median":-11.610032,"eighty":-8.383446,"marketCap":25161347},{"date":"2021-06-25","current":-7.276025,"twenty":-36.938566,"median":-11.606813,"eighty":-8.383446,"marketCap":27134786},{"date":"2021-07-02","current":-6.088049,"twenty":-36.938566,"median":-11.543264,"eighty":-8.169095,"marketCap":22704415},{"date":"2021-07-09","current":-5.688529,"twenty":-36.938566,"median":-11.446551,"eighty":-8.132075,"marketCap":21214469},{"date":"2021-07-16","current":-5.291655,"twenty":-36.938566,"median":-11.336275,"eighty":-7.933662,"marketCap":19734390},{"date":"2021-07-23","current":-4.497906,"twenty":-36.938566,"median":-11.33271,"eighty":-7.930287,"marketCap":16774231},{"date":"2021-07-30","current":-4.167178,"twenty":-36.938566,"median":-11.331617,"eighty":-7.8797,"marketCap":15540832},{"date":"2021-08-06","current":-4.931822,"twenty":-36.938566,"median":-11.316925,"eighty":-7.772559,"marketCap":18392451},{"date":"2021-08-13","current":-6.194366,"twenty":-36.938566,"median":-11.316925,"eighty":-7.71145,"marketCap":17445200},{"date":"2021-08-20","current":-5.773934,"twenty":-36.938566,"median":-11.316925,"eighty":-7.530024,"marketCap":16261137},{"date":"2021-08-27","current":-5.780941,"twenty":-36.938566,"median":-11.316925,"eighty":-7.471816,"marketCap":16280871},{"date":"2021-09-03","current":-6.250424,"twenty":-36.938566,"median":-11.316925,"eighty":-7.408317,"marketCap":17603075},{"date":"2021-09-10","current":-5.938604,"twenty":-36.938566,"median":-11.316925,"eighty":-7.287866,"marketCap":16724895},{"date":"2021-09-17","current":-6.131302,"twenty":-36.938566,"median":-11.316925,"eighty":-7.030065,"marketCap":17267591},{"date":"2021-09-24","current":-6.481662,"twenty":-36.938566,"median":-11.316925,"eighty":-6.998719,"marketCap":18254310},{"date":"2021-10-01","current":-7.777994,"twenty":-36.938566,"median":-11.316925,"eighty":-6.998719,"marketCap":21905172},{"date":"2021-10-08","current":-7.991714,"twenty":-36.938566,"median":-11.294692,"eighty":-6.998719,"marketCap":22507071},{"date":"2021-10-15","current":-7.245447,"twenty":-36.938566,"median":-11.250677,"eighty":-6.998719,"marketCap":20405359},{"date":"2021-10-22","current":-6.485165,"twenty":-36.938566,"median":-11.169737,"eighty":-6.998719,"marketCap":18264177},{"date":"2021-10-29","current":-7.007202,"twenty":-36.938566,"median":-11.007857,"eighty":-6.998719,"marketCap":19734390},{"date":"2021-11-05","current":-6.989684,"twenty":-36.938566,"median":-10.863315,"eighty":-6.998719,"marketCap":19685054},{"date":"2021-11-12","current":4.813136,"twenty":-36.938566,"median":-10.781763,"eighty":-6.998719,"marketCap":20227749},{"date":"2021-11-19","current":4.578349,"twenty":-36.938566,"median":-10.765666,"eighty":-6.895555,"marketCap":19241030},{"date":"2021-11-26","current":4.425738,"twenty":-36.92924,"median":-10.765666,"eighty":-6.877034,"marketCap":18599662},{"date":"2021-12-03","current":3.873988,"twenty":-36.923022,"median":-10.684096,"eighty":-6.855846,"marketCap":16280871},{"date":"2021-12-10","current":3.648592,"twenty":-36.923022,"median":-10.684096,"eighty":-6.83062,"marketCap":15333621},{"date":"2021-12-17","current":3.744855,"twenty":-36.923022,"median":-10.417366,"eighty":-6.773318,"marketCap":15738176},{"date":"2021-12-23","current":3.169626,"twenty":-36.923022,"median":-10.364594,"eighty":-6.667326,"marketCap":13320713},{"date":"2021-12-31","current":3.345717,"twenty":-36.923022,"median":-10.273294,"eighty":-6.629914,"marketCap":14060752},{"date":"2022-01-07","current":3.39737,"twenty":-36.923022,"median":-10.104326,"eighty":-6.509381,"marketCap":14277831},{"date":"2022-01-14","current":3.709637,"twenty":-36.923022,"median":-10.104326,"eighty":-6.481662,"marketCap":15590168},{"date":"2022-01-21","current":3.756594,"twenty":-36.311797,"median":-10.104326,"eighty":-6.32658,"marketCap":15787512},{"date":"2022-01-28","current":3.991381,"twenty":-33.866898,"median":-10.104326,"eighty":-6.195768,"marketCap":16774231},{"date":"2022-02-04","current":4.460956,"twenty":-33.866898,"median":-10.072513,"eighty":-6.085932,"marketCap":18747670},{"date":"2022-02-11","current":4.554871,"twenty":-33.866898,"median":-10.040701,"eighty":-5.953713,"marketCap":19142358},{"date":"2022-02-18","current":3.780061,"twenty":-33.57661,"median":-9.745323,"eighty":-5.886049,"marketCap":15886135},{"date":"2022-02-25","current":4.460942,"twenty":-32.41546,"median":-9.734304,"eighty":-5.84751,"marketCap":18747613},{"date":"2022-03-04","current":4.233199,"twenty":-32.41546,"median":-9.713568,"eighty":-5.832266,"marketCap":17790498},{"date":"2022-03-11","current":3.521796,"twenty":-32.41546,"median":-9.66205,"eighty":-5.815977,"marketCap":14800747},{"date":"2022-03-18","current":3.406751,"twenty":-32.41546,"median":-9.66205,"eighty":-5.773934,"marketCap":14317256},{"date":"2022-03-25","current":3.573449,"twenty":-32.41546,"median":-9.66205,"eighty":-5.635612,"marketCap":15017825},{"date":"2022-04-01","current":5.560776,"twenty":-32.41546,"median":-9.66205,"eighty":-5.574758,"marketCap":21707829},{"date":"2022-04-08","current":6.268511,"twenty":-32.41546,"median":-9.66205,"eighty":-5.291655,"marketCap":24470643},{"date":"2022-04-14","current":5.310541,"twenty":-32.41546,"median":-9.66205,"eighty":-4.855357,"marketCap":20730976},{"date":"2022-04-22","current":4.4284,"twenty":-32.41546,"median":-9.66205,"eighty":-4.615857,"marketCap":17287325},{"date":"2022-04-29","current":3.98101,"twenty":-32.286443,"median":-9.622366,"eighty":-4.520661,"marketCap":15540832},{"date":"2022-05-06","current":4.233772,"twenty":-32.254189,"median":-9.596752,"eighty":-4.418002,"marketCap":16527551},{"date":"2022-05-13","current":3.409218,"twenty":-32.254189,"median":-9.596752,"eighty":-2.602183,"marketCap":14422258},{"date":"2022-05-20","current":3.406869,"twenty":-32.254189,"median":-9.596752,"eighty":3.174322,"marketCap":14412318},{"date":"2022-05-27","current":3.406869,"twenty":-32.254189,"median":-9.596752,"eighty":3.294533,"marketCap":14412318},{"date":"2022-06-03","current":3.406869,"twenty":-32.254189,"median":-9.540285,"eighty":3.400187,"marketCap":14412318},{"date":"2022-06-10","current":3.406869,"twenty":-32.254189,"median":-9.499117,"eighty":3.406869,"marketCap":14412318},{"date":"2022-06-17","current":3.059133,"twenty":-32.254189,"median":-9.499117,"eighty":3.406869,"marketCap":12941268},{"date":"2022-06-24","current":2.58781,"twenty":-32.254189,"median":-9.499117,"eighty":3.406869,"marketCap":10947398},{"date":"2022-07-01","current":2.584521,"twenty":-32.254189,"median":-9.499117,"eighty":3.406869,"marketCap":10933483},{"date":"2022-07-08","current":2.583346,"twenty":-32.254189,"median":-9.499117,"eighty":3.406845,"marketCap":10928513},{"date":"2022-07-15","current":3.049735,"twenty":-32.254189,"median":-9.499117,"eighty":3.406516,"marketCap":12901509},{"date":"2022-07-22","current":3.28939,"twenty":-32.254189,"median":-9.392914,"eighty":3.406516,"marketCap":13915342},{"date":"2022-07-29","current":3.251797,"twenty":-32.254189,"median":-9.320616,"eighty":3.405344,"marketCap":13756309},{"date":"2022-08-05","current":3.44955,"twenty":-32.254189,"median":-9.279879,"eighty":3.406845,"marketCap":13915342},{"date":"2022-08-12","current":3.264752,"twenty":-32.254189,"median":-9.230967,"eighty":3.406869,"marketCap":13169877},{"date":"2022-08-19","current":3.327583,"twenty":-32.254189,"median":-9.1175,"eighty":3.406869,"marketCap":13423335},{"date":"2022-08-26","current":3.397806,"twenty":-32.254189,"median":-9.1175,"eighty":3.406869,"marketCap":13706611},{"date":"2022-09-02","current":4.452383,"twenty":-32.254189,"median":-9.1175,"eighty":3.406869,"marketCap":17960730},{"date":"2022-09-09","current":4.893432,"twenty":-32.254189,"median":-9.1175,"eighty":3.406869,"marketCap":19739906},{"date":"2022-09-16","current":4.188739,"twenty":-32.254189,"median":-9.115932,"eighty":3.406869,"marketCap":16897201},{"date":"2022-09-23","current":3.529628,"twenty":-32.254189,"median":-9.074418,"eighty":3.406869,"marketCap":14238376},{"date":"2022-09-30","current":4.184954,"twenty":-32.254189,"median":-9.074418,"eighty":3.406869,"marketCap":16881934},{"date":"2022-10-07","current":4.426095,"twenty":-32.254189,"median":-9.074418,"eighty":3.409218,"marketCap":17854685},{"date":"2022-10-14","current":3.920478,"twenty":-32.254189,"median":-9.074418,"eighty":3.417518,"marketCap":15815046},{"date":"2022-10-21","current":3.337073,"twenty":-32.254189,"median":-9.074418,"eighty":3.429838,"marketCap":13461616},{"date":"2022-10-28","current":2.971473,"twenty":-32.254189,"median":-9.074418,"eighty":3.429838,"marketCap":11986800},{"date":"2022-11-04","current":2.917022,"twenty":-32.254189,"median":-9.074418,"eighty":3.422022,"marketCap":11767147},{"date":"2022-11-11","current":-3.27585,"twenty":-32.254189,"median":-9.074418,"eighty":3.417518,"marketCap":10923013},{"date":"2022-11-18","current":-3.341743,"twenty":-32.254189,"median":-9.074418,"eighty":3.416143,"marketCap":11142729},{"date":"2022-11-25","current":-3.426464,"twenty":-32.254189,"median":-9.074418,"eighty":3.410603,"marketCap":11425221},{"date":"2022-12-02","current":-3.30409,"twenty":-32.254189,"median":-9.074418,"eighty":3.409218,"marketCap":11017177},{"date":"2022-12-09","current":-3.435877,"twenty":-32.254189,"median":-8.907073,"eighty":3.409218,"marketCap":11456609},{"date":"2022-12-16","current":-2.456887,"twenty":-32.254189,"median":-8.834559,"eighty":3.409218,"marketCap":8192260},{"date":"2022-12-23","current":-2.824009,"twenty":-32.254189,"median":-8.772618,"eighty":3.409218,"marketCap":9416391},{"date":"2022-12-30","current":-3.162889,"twenty":-29.11202,"median":-8.622853,"eighty":3.409218,"marketCap":10546357},{"date":"2023-01-06","current":-2.654568,"twenty":-29.11202,"median":-8.622853,"eighty":3.406869,"marketCap":8851407},{"date":"2023-01-13","current":-2.663981,"twenty":-29.11202,"median":-8.622853,"eighty":3.406869,"marketCap":8882795},{"date":"2023-01-20","current":-2.447474,"twenty":-29.11202,"median":-8.622853,"eighty":3.406869,"marketCap":8160872},{"date":"2023-01-27","current":-2.412456,"twenty":-29.11202,"median":-8.622853,"eighty":3.400449,"marketCap":8044108},{"date":"2023-02-03","current":-2.546314,"twenty":-29.11202,"median":-8.622853,"eighty":3.333597,"marketCap":8490445},{"date":"2023-02-10","current":-2.343927,"twenty":-29.11202,"median":-8.622853,"eighty":3.313409,"marketCap":7815604},{"date":"2023-02-17","current":-2.551021,"twenty":-29.11202,"median":-8.622853,"eighty":3.284213,"marketCap":8506139},{"date":"2023-02-24","current":-2.118006,"twenty":-29.11202,"median":-8.622853,"eighty":3.258389,"marketCap":7062293},{"date":"2023-03-03","current":-2.230966,"twenty":-29.11202,"median":-8.622853,"eighty":3.220613,"marketCap":7438948},{"date":"2023-03-10","current":-2.05842,"twenty":-29.11202,"median":-8.622853,"eighty":3.203153,"marketCap":6863607},{"date":"2023-03-17","current":-1.788539,"twenty":-29.11202,"median":-8.622853,"eighty":3.169626,"marketCap":5963714},{"date":"2023-03-24","current":-1.664842,"twenty":-29.11202,"median":-8.622853,"eighty":3.109923,"marketCap":6507121},{"date":"2023-03-31","current":-1.697169,"twenty":-28.064631,"median":-8.622853,"eighty":3.062449,"marketCap":6633473},{"date":"2023-04-06","current":-1.818396,"twenty":-29.11202,"median":-8.622853,"eighty":3.028188,"marketCap":7107293},{"date":"2023-04-14","current":-1.922974,"twenty":-30.15941,"median":-8.623987,"eighty":2.91391,"marketCap":7516041},{"date":"2023-04-21","current":-1.74566,"twenty":-30.15941,"median":-8.623987,"eighty":2.672645,"marketCap":6823001},{"date":"2023-04-28","current":-1.810314,"twenty":-30.15941,"median":-8.623987,"eighty":2.584521,"marketCap":7075705},{"date":"2023-05-05","current":-1.757783,"twenty":-30.15941,"median":-8.623987,"eighty":2.535419,"marketCap":6870383},{"date":"2023-05-12","current":-1.761823,"twenty":-30.15941,"median":-8.623987,"eighty":2.380579,"marketCap":6886177},{"date":"2023-05-19","current":-1.552815,"twenty":-30.15941,"median":-8.613691,"eighty":0.794614,"marketCap":6538709},{"date":"2023-05-26","current":-1.560316,"twenty":-30.15941,"median":-8.610026,"eighty":0.794614,"marketCap":6570297},{"date":"2023-06-02","current":-1.62783,"twenty":-30.15941,"median":-8.509394,"eighty":0.794614,"marketCap":6854589},{"date":"2023-06-09","current":-1.665338,"twenty":-26.666627,"median":-8.509394,"eighty":0.794614,"marketCap":7012529},{"date":"2023-06-16","current":-1.635332,"twenty":-26.666627,"median":-8.444803,"eighty":0.794614,"marketCap":6886177},{"date":"2023-06-23","current":-1.567818,"twenty":-26.584576,"median":-8.44366,"eighty":1.57209,"marketCap":6601885},{"date":"2023-06-30","current":-1.567818,"twenty":-24.605518,"median":-8.44366,"eighty":2.349565,"marketCap":6601885},{"date":"2023-07-07","current":-1.515307,"twenty":-22.589384,"median":-8.44366,"eighty":2.349565,"marketCap":6380769},{"date":"2023-07-14","current":-1.53031,"twenty":-22.589384,"median":-8.44366,"eighty":2.349565,"marketCap":6443945},{"date":"2023-07-21","current":-1.515307,"twenty":-22.589384,"median":-8.44366,"eighty":2.349565,"marketCap":6380769},{"date":"2023-07-28","current":-1.447794,"twenty":-17.695018,"median":-8.396566,"eighty":2.349565,"marketCap":6096478},{"date":"2023-08-04","current":-1.620329,"twenty":-16.942038,"median":-8.383446,"eighty":2.349565,"marketCap":6823001},{"date":"2023-08-11","current":-1.53031,"twenty":-15.812569,"median":-8.383446,"eighty":2.349565,"marketCap":6443945},{"date":"2023-08-18","current":-1.299164,"twenty":-15.812569,"median":-8.383446,"eighty":2.349565,"marketCap":5931235},{"date":"2023-08-25","current":-1.29074,"twenty":-15.436079,"median":-8.383446,"eighty":2.349565,"marketCap":5892777},{"date":"2023-09-01","current":-1.285306,"twenty":-15.05959,"median":-8.212006,"eighty":2.349565,"marketCap":5867966},{"date":"2023-09-08","current":-1.365467,"twenty":-14.569222,"median":-8.130215,"eighty":2.349565,"marketCap":6233938},{"date":"2023-09-15","current":-1.317914,"twenty":-14.083581,"median":-7.962688,"eighty":2.349565,"marketCap":6016836},{"date":"2023-09-22","current":-1.24998,"twenty":-13.921701,"median":-7.930287,"eighty":2.349565,"marketCap":5706690},{"date":"2023-09-29","current":-1.14808,"twenty":-13.600564,"median":-7.8461,"eighty":2.349565,"marketCap":5241470},{"date":"2023-10-06","current":-1.086939,"twenty":-13.600564,"median":-7.772559,"eighty":2.349565,"marketCap":4962339},{"date":"2023-10-13","current":-1.032592,"twenty":-13.600564,"median":-7.692175,"eighty":2.349565,"marketCap":4714222},{"date":"2023-10-20","current":-0.889932,"twenty":-13.59794,"median":-7.548901,"eighty":2.349565,"marketCap":4062915},{"date":"2023-10-27","current":-0.910312,"twenty":-13.594777,"median":-7.495615,"eighty":2.380579,"marketCap":4155959},{"date":"2023-11-03","current":-1.032592,"twenty":-13.594777,"median":-7.408317,"eighty":2.380579,"marketCap":4714222},{"date":"2023-11-10","current":-1.019006,"twenty":-13.177141,"median":-7.342171,"eighty":2.380579,"marketCap":4652193},{"date":"2023-11-17","current":-1.0893,"twenty":-13.177141,"median":-7.269972,"eighty":2.380579,"marketCap":4621178},{"date":"2023-11-24","current":-1.235413,"twenty":-12.975635,"median":-7.182382,"eighty":2.380579,"marketCap":5241041},{"date":"2023-12-01","current":-1.106873,"twenty":-12.629773,"median":-7.007202,"eighty":2.380579,"marketCap":4695731},{"date":"2023-12-08","current":-1.056743,"twenty":-12.418157,"median":-6.998719,"eighty":2.370241,"marketCap":4483060},{"date":"2023-12-15","current":-1.071168,"twenty":-12.212374,"median":-6.998719,"eighty":2.370241,"marketCap":4544256},{"date":"2023-12-22","current":-1.121156,"twenty":-11.979138,"median":-6.998719,"eighty":2.380579,"marketCap":4756321},{"date":"2023-12-29","current":-1.016895,"twenty":-11.920554,"median":-6.89238,"eighty":2.390917,"marketCap":4314013},{"date":"2024-01-05","current":-1.064026,"twenty":-11.920554,"median":-6.873859,"eighty":2.401255,"marketCap":4513960},{"date":"2024-01-12","current":-1.060456,"twenty":-11.655378,"median":-6.832022,"eighty":2.401255,"marketCap":4498813},{"date":"2024-01-19","current":-1.014039,"twenty":-11.628829,"median":-6.811682,"eighty":2.40197,"marketCap":4301895},{"date":"2024-01-26","current":-0.917708,"twenty":-11.610032,"median":-6.667485,"eighty":2.401255,"marketCap":3893229},{"date":"2024-02-02","current":-0.966981,"twenty":-11.610032,"median":-6.622506,"eighty":2.401255,"marketCap":4102262},{"date":"2024-02-09","current":-0.942345,"twenty":-11.610032,"median":-6.485165,"eighty":2.401255,"marketCap":3997746},{"date":"2024-02-16","current":-0.960822,"twenty":-11.543264,"median":-6.357923,"eighty":2.401255,"marketCap":4076133},{"date":"2024-02-23","current":-0.942345,"twenty":-11.336275,"median":-6.201374,"eighty":2.401255,"marketCap":3997746},{"date":"2024-03-01","current":-0.9793,"twenty":-11.331617,"median":-6.086726,"eighty":2.390917,"marketCap":4154520},{"date":"2024-03-08","current":-0.948504,"twenty":-11.316925,"median":-5.949361,"eighty":2.390917,"marketCap":4023875},{"date":"2024-03-15","current":-1.040891,"twenty":-11.316925,"median":-5.851013,"eighty":2.390917,"marketCap":4415811},{"date":"2024-03-22","current":-1.120959,"twenty":-11.316925,"median":-5.832266,"eighty":2.390917,"marketCap":4755488},{"date":"2024-03-28","current":-1.467659,"twenty":-11.316925,"median":-5.824122,"eighty":2.390917,"marketCap":5431340},{"date":"2024-04-05","current":-1.5153,"twenty":-11.299241,"median":-5.742402,"eighty":2.401255,"marketCap":5607646},{"date":"2024-04-12","current":-1.452291,"twenty":-11.299241,"median":-5.609265,"eighty":2.401255,"marketCap":5374468},{"date":"2024-04-19","current":-1.513763,"twenty":-11.299241,"median":-5.418654,"eighty":2.401255,"marketCap":5601958},{"date":"2024-04-26","current":-1.444684,"twenty":-11.298331,"median":-4.796223,"eighty":2.390917,"marketCap":5346316},{"date":"2024-05-03","current":-1.421554,"twenty":-11.294692,"median":-4.589716,"eighty":2.390917,"marketCap":5260722},{"date":"2024-05-10","current":-1.352398,"twenty":-11.137361,"median":-4.492615,"eighty":2.390917,"marketCap":5004795},{"date":"2024-05-17","current":-1.486679,"twenty":-11.007857,"median":-4.094418,"eighty":2.390917,"marketCap":5346031},{"date":"2024-05-24","current":-1.573666,"twenty":-11.007857,"median":-3.431171,"eighty":2.390917,"marketCap":5658831},{"date":"2024-05-31","current":-1.581574,"twenty":-11.007857,"median":-3.393517,"eighty":2.390917,"marketCap":5687268},{"date":"2024-06-07","current":-0.919921,"twenty":-11.007857,"median":-3.341743,"eighty":2.390917,"marketCap":3307995},{"date":"2024-06-14","current":-1.240562,"twenty":-11.007857,"median":-3.294676,"eighty":2.401255,"marketCap":4461005},{"date":"2024-06-21","current":-1.013211,"twenty":-11.007857,"median":-3.162889,"eighty":2.40197,"marketCap":3643461},{"date":"2024-06-28","current":-0.994603,"twenty":-11.007857,"median":-3.040516,"eighty":2.404114,"marketCap":3576546},{"date":"2024-07-05","current":-0.979121,"twenty":-11.007857,"median":-2.880488,"eighty":2.404114,"marketCap":3520875},{"date":"2024-07-12","current":-1.004753,"twenty":-11.007857,"median":-2.720461,"eighty":2.404114,"marketCap":3613045},{"date":"2024-07-15","current":-1.03551,"twenty":-11.007857,"median":-2.701635,"eighty":2.404114,"marketCap":3723648},{"date":"2024-08-02","current":-2.46286,"twenty":-10.719359,"median":-2.605383,"eighty":2.485523,"marketCap":8856333},{"date":"2024-08-09","current":-1.534647,"twenty":-10.586968,"median":-2.551021,"eighty":2.485523,"marketCap":5518519},{"date":"2024-08-16","current":-1.735203,"twenty":-10.362651,"median":-2.475667,"eighty":2.485523,"marketCap":6098860},{"date":"2024-08-23","current":-1.786238,"twenty":-10.362651,"median":-2.45218,"eighty":2.485523,"marketCap":6278238},{"date":"2024-08-30","current":-1.531061,"twenty":-10.362651,"median":-2.411138,"eighty":2.485523,"marketCap":5381347},{"date":"2024-09-06","current":-1.531061,"twenty":-10.207138,"median":-2.361577,"eighty":2.485523,"marketCap":5381347},{"date":"2024-09-13","current":-1.377955,"twenty":-10.104326,"median":-2.230966,"eighty":2.485523,"marketCap":4843212},{"date":"2024-09-20","current":-1.352438,"twenty":-10.066151,"median":-2.149851,"eighty":2.485523,"marketCap":4753523},{"date":"2024-09-27","current":-1.352438,"twenty":-9.745323,"median":-2.089766,"eighty":2.485523,"marketCap":4753523},{"date":"2024-10-04","current":-1.301402,"twenty":-9.664984,"median":-1.937601,"eighty":2.485523,"marketCap":4574145},{"date":"2024-10-11","current":-1.301402,"twenty":-9.53737,"median":-1.901283,"eighty":2.485523,"marketCap":4574145},{"date":"2024-10-18","current":-1.531061,"twenty":-9.53737,"median":-1.842296,"eighty":2.485523,"marketCap":5381347},{"date":"2024-10-25","current":-1.45285,"twenty":-9.392914,"median":-1.815076,"eighty":2.485523,"marketCap":5106450},{"date":"2024-10-31","current":-1.441749,"twenty":-9.256878,"median":-1.798474,"eighty":2.485523,"marketCap":5067435},{"date":"2024-11-08","current":-1.633132,"twenty":-9.1175,"median":-1.781386,"eighty":2.494763,"marketCap":5740103},{"date":"2024-11-15","current":-1.363079,"twenty":-9.1175,"median":-1.761823,"eighty":2.494763,"marketCap":5157124},{"date":"2024-11-22","current":-1.078611,"twenty":-9.074418,"median":-1.741472,"eighty":2.494763,"marketCap":4080854},{"date":"2024-11-29","current":-1.185287,"twenty":-9.074418,"median":-1.737578,"eighty":2.494763,"marketCap":4484456},{"date":"2024-12-06","current":-1.102317,"twenty":-9.074418,"median":-1.72535,"eighty":2.494763,"marketCap":4170544},{"date":"2024-12-13","current":-1.092834,"twenty":-9.074418,"median":-1.697169,"eighty":2.494763,"marketCap":4134668},{"date":"2024-12-20","current":-0.989596,"twenty":-9.074418,"median":-1.683161,"eighty":2.494763,"marketCap":3744072},{"date":"2024-12-27","current":-1.127444,"twenty":-9.074418,"median":-1.665338,"eighty":2.494763,"marketCap":4265614},{"date":"2025-01-03","current":-1.126022,"twenty":-9.074418,"median":-1.650335,"eighty":2.494763,"marketCap":4260233},{"date":"2025-01-10","current":-2.02684,"twenty":-9.074418,"median":-1.643238,"eighty":2.504003,"marketCap":7668419},{"date":"2025-01-17","current":-2.346867,"twenty":-9.074418,"median":-1.643238,"eighty":2.504003,"marketCap":8879222},{"date":"2025-01-24","current":-2.323162,"twenty":-9.074418,"median":-1.643238,"eighty":2.504003,"marketCap":8789533},{"date":"2025-01-31","current":-2.169074,"twenty":-9.074418,"median":-1.643238,"eighty":2.504003,"marketCap":8206554},{"date":"2025-02-07","current":-1.967576,"twenty":-9.074418,"median":-1.643238,"eighty":2.504003,"marketCap":7444196},{"date":"2025-02-14","current":-1.789783,"twenty":-9.074418,"median":-1.643238,"eighty":2.504003,"marketCap":6771528},{"date":"2025-02-21","current":-1.766077,"twenty":-9.074418,"median":-1.643238,"eighty":2.504003,"marketCap":6681839},{"date":"2025-02-28","current":-1.635695,"twenty":-9.074418,"median":-1.634232,"eighty":2.504003,"marketCap":6188549},{"date":"2025-03-07","current":-1.552725,"twenty":-8.780536,"median":-1.620329,"eighty":2.513243,"marketCap":5874637},{"date":"2025-03-14","current":-1.564578,"twenty":-8.412491,"median":-1.608904,"eighty":2.513243,"marketCap":5919481},{"date":"2025-03-21","current":-1.623842,"twenty":-8.140487,"median":-1.608904,"eighty":2.513243,"marketCap":6143704},{"date":"2025-03-28","current":-1.564578,"twenty":-8.140487,"median":-1.606063,"eighty":2.513243,"marketCap":5919481},{"date":"2025-04-04","current":-1.128035,"twenty":-8.140487,"median":-1.600137,"eighty":2.513243,"marketCap":4955323},{"date":"2025-04-11","current":-1.06168,"twenty":-8.138805,"median":-1.588883,"eighty":2.504003,"marketCap":4663834},{"date":"2025-04-17","current":-1.051472,"twenty":-8.138805,"median":-1.582871,"eighty":2.504003,"marketCap":4618989},{"date":"2025-04-25","current":-1.163765,"twenty":-8.140487,"median":-1.575319,"eighty":2.513243,"marketCap":5112279},{"date":"2025-05-02","current":-0.79626,"twenty":-8.128354,"median":-1.569338,"eighty":2.513243,"marketCap":3497875},{"date":"2025-05-09","current":-0.831888,"twenty":-7.906284,"median":-1.567818,"eighty":2.513243,"marketCap":3654383},{"date":"2025-05-16","current":-0.504357,"twenty":-7.789967,"median":-1.560316,"eighty":2.513243,"marketCap":2331468},{"date":"2025-05-23","current":-0.666884,"twenty":-7.667608,"median":-1.552725,"eighty":2.513243,"marketCap":3082772},{"date":"2025-05-30","current":-0.73627,"twenty":-7.530024,"median":-1.545313,"eighty":2.513243,"marketCap":3403519},{"date":"2025-06-05","current":-0.890322,"twenty":-7.471816,"median":-1.537812,"eighty":2.513243,"marketCap":4115649}],"updateTime":1749259888665}}}